Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 12

Trial Status

Completed2

Role Distribution

Principal Investigator2
PI Rate100%

Activity Timeline

Clinical Trials (2)

NCT00455052Phase 1Completed
A Study of Intravenous XMT-1001 in Patients With Advanced Solid Tumors
Non-small Cell Lung CancerSmall Cell Lung Cancer
PrincipalinvestigatorStart date: 2011-03-01
NCT01837667Phase 1Completed
Phase I Study of LB-100 With Docetaxel in Solid Tumors
CancerNeoplasmsTumors
Principalinvestigator

Research Network

Collaboration Network

16 collaborators·50 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Affiliations

Comprehensive Cancer Centers of Nevada

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Aaron Mansfield, MD

Mayo Clinic

Moderately Similar
2 trials

Shared therapeutic areas:

CancerCarcinoma, Non-Small-Cell LungNeoplasms

Worked with same sponsors:

Lixte Biotechnology Holdings, Inc.
Collaborated on 1 trial
Similarity Score34%

Edward Sausville, MD

University of Maryland Greenebaum Cancer Center

Related
1 trials

Shared therapeutic areas:

Carcinoma, Non-Small-Cell LungSmall Cell Lung Carcinoma

Worked with same sponsors:

Mersana Therapeutics
Collaborated on 1 trial
Similarity Score24%

Allen Lee Cohn, MD

Rocky Mountain Cancer Centers

Related
1 trials

Shared therapeutic areas:

Carcinoma, Non-Small-Cell LungSmall Cell Lung Carcinoma

Worked with same sponsors:

Mersana Therapeutics
Collaborated on 1 trial
Similarity Score24%

Donald A. Richards, MD

Texas Oncology - Tyler

Related
1 trials

Shared therapeutic areas:

Carcinoma, Non-Small-Cell LungSmall Cell Lung Carcinoma

Worked with same sponsors:

Mersana Therapeutics
Collaborated on 1 trial
Similarity Score24%

Paul R. Conkling, MD

Virginia Oncology Associates

Related
1 trials

Shared therapeutic areas:

Carcinoma, Non-Small-Cell LungSmall Cell Lung Carcinoma

Worked with same sponsors:

Mersana Therapeutics
Collaborated on 1 trial
Similarity Score24%

Carlos Becerra, MD

Texas Oncology - Baylor Charles A Sammons Cancer Center

Related
1 trials

Shared therapeutic areas:

CancerNeoplasms

Worked with same sponsors:

Lixte Biotechnology Holdings, Inc.
Collaborated on 1 trial
Similarity Score24%

Donald Richards, MD

Texas Oncology - Tyler

Related
1 trials

Shared therapeutic areas:

CancerNeoplasms

Worked with same sponsors:

Lixte Biotechnology Holdings, Inc.
Collaborated on 1 trial
Similarity Score24%

Glen J Weiss, MD

TGen Clinical Research Services at Scottsdale Healthcare

Related
2 trials

Shared therapeutic areas:

Carcinoma, Non-Small-Cell LungSmall Cell Lung Carcinoma

Worked with same sponsors:

Mersana Therapeutics
Collaborated on 1 trial
Similarity Score24%

Lawrence Garbo, MD

New York Oncology Hematology

Related
1 trials

Shared therapeutic areas:

Carcinoma, Non-Small-Cell LungSmall Cell Lung Carcinoma

Worked with same sponsors:

Mersana Therapeutics
Collaborated on 1 trial
Similarity Score24%

Hillary H. Wu, MD

Central Indiana Cancer Centers

Related
1 trials

Shared therapeutic areas:

Carcinoma, Non-Small-Cell LungSmall Cell Lung Carcinoma

Worked with same sponsors:

Mersana Therapeutics
Collaborated on 1 trial
Similarity Score24%

Publications (0)

No publications found for this investigator.

Clinical Trials (2)

Showing 2 of 2 trials

NCT00455052Phase 1PrincipalInvestigator

A Study of Intravenous XMT-1001 in Patients With Advanced Solid Tumors

Non-small Cell Lung CancerSmall Cell Lung Cancer
Completed
NCT01837667Phase 1PrincipalInvestigator

Phase I Study of LB-100 With Docetaxel in Solid Tumors

CancerNeoplasmsTumors
Completed

All 2 trials loaded